Centers for Disease Control and Prevention. National Diabetes Statistics Report https://www.cdc.gov/diabetes/php/data-research/index.html (2024).

Hussain, S. et al. Diabetic kidney disease: an overview of prevalence, risk factors, and biomarkers. Clin. Epidemiol. Glob. Health 9, 2–6 (2021).

Article  CAS  Google Scholar 

Tuttle, K. R. et al. Diabetic kidney disease: a report from an ADA consensus conference. Diabetes Care 37, 2864–2883 (2014).

Article  PubMed  PubMed Central  Google Scholar 

Hoogeveen, E. K. The epidemiology of diabetic kidney disease. Kidney Dialysis 2, 433–442 (2022).

Article  Google Scholar 

Afkarian, M. et al. Kidney disease and increased mortality risk in type 2 diabetes. J. Am. Soc. Nephrol. 24, 302–308 (2013).

Article  CAS  PubMed  PubMed Central  Google Scholar 

González-Pérez, A., Saez, M., Vizcaya, D., Lind, M. & Garcia Rodriguez, L. Incidence and risk factors for mortality and end-stage renal disease in people with type 2 diabetes and diabetic kidney disease: a population-based cohort study in the UK. BMJ Open Diabetes Res. Care 9, e002146 (2021).

Article  PubMed  PubMed Central  Google Scholar 

Liao, X. et al. Contribution of CKD to mortality in middle-aged and elderly people with diabetes: the China health and retirement longitudinal study. Diabetol. Metab. Syndr. 15, 122 (2023).

Article  CAS  PubMed  PubMed Central  Google Scholar 

Reidy, K., Kang, H. M., Hostetter, T. & Susztak, K. Molecular mechanisms of diabetic kidney disease. J. Clin. Investig. 124, 2333–2340 (2014).

Article  CAS  PubMed  PubMed Central  Google Scholar 

Yamazaki, T., Mimura, I., Tanaka, T. & Nangaku, M. Treatment of diabetic kidney disease: current and future. Diabetes Metab. J. 45, 11–26 (2021).

Article  PubMed  PubMed Central  Google Scholar 

Petrazzuolo, A. et al. Broadening horizons in mechanisms, management, and treatment of diabetic kidney disease. Pharmacol. Res. 190, 106710 (2023).

Article  CAS  PubMed  Google Scholar 

Winiarska, A., Knysak, M., Nabrdalik, K., Gumprecht, J. & Stompór, T. Inflammation and oxidative stress in diabetic kidney disease: the targets for SGLT2 inhibitors and GLP-1 receptor agonists. Int. J. Mol. Sci. 22, 10822 (2021).

Article  CAS  PubMed  PubMed Central  Google Scholar 

Zinman, B. et al. Empagliflozin, cardiovascular outcomes, and mortality in type 2 diabetes. N. Engl. J. Med. 373, 2117–2128 (2015).

Article  CAS  PubMed  Google Scholar 

Marso, S. P. et al. Semaglutide and cardiovascular outcomes in patients with type 2 diabetes. N. Engl. J. Med. 375, 1834–1844 (2016).

Article  CAS  PubMed  Google Scholar 

Marso, S. P. et al. Liraglutide and cardiovascular outcomes in type 2 diabetes. N. Engl. J. Med. 375, 311–322 (2016).

Article  CAS  PubMed  PubMed Central  Google Scholar 

Persson, F. et al. Changes in albuminuria predict cardiovascular and renal outcomes in type 2 diabetes: a post hoc analysis of the LEADER trial. Diabetes Care 44, 1020–1026 (2021).

Article  PubMed  PubMed Central  Google Scholar 

Tuttle, K. R. et al. Post hoc analysis of SUSTAIN 6 and PIONEER 6 trials suggests that people with type 2 diabetes at high cardiovascular risk treated with semaglutide experience more stable kidney function compared with placebo. Kidney Int. 103, 772–781 (2023).

Article  PubMed  Google Scholar 

Perkovic, V. et al. Effects of semaglutide on chronic kidney disease in patients with type 2 diabetes. N. Engl. J. Med. 391, 109–121 (2024).

Article  CAS  PubMed  Google Scholar 

Barrera-Chimal, J. & Jaisser, F. Pathophysiologic mechanisms in diabetic kidney disease: a focus on current and future therapeutic targets. Diabetes Obes. Metab. 22, 16–31 (2020).

Article  CAS  PubMed  Google Scholar 

Tervaert, T. W. et al. Pathologic classification of diabetic nephropathy. J. Am. Soc. Nephrol. 21, 556–563 (2010).

Article  PubMed  Google Scholar 

Scilletta, S. et al. Update on diabetic kidney disease (DKD): focus on non-albuminuric DKD and cardiovascular risk. Biomolecules 13, 752 (2023).

Article  CAS  PubMed  PubMed Central  Google Scholar 

Qi, C., Mao, X., Zhang, Z. & Wu, H. Classification and differential diagnosis of diabetic nephropathy. J. Diabetes Res. 2017, 1–7 (2017).

Google Scholar 

Oshima, M. et al. Trajectories of kidney function in diabetes: a clinicopathological update. Nat. Rev. Nephrol. 17, 740–750 (2021).

Article  PubMed  Google Scholar 

Alicic, R. Z. R., Michele, T. & Tuttle, K. R. Diabetic kidney disease. Clin. J. Am. Soc. Nephrol. 12, 2032–2045 (2017).

Article  CAS  PubMed  PubMed Central  Google Scholar 

Umanath, K. & Lewis, J. B. Update on diabetic nephropathy: core curriculum 2018. Am. J. Kidney Dis. 71, 884–895 (2018).

Article  PubMed  Google Scholar 

Park, C. W. Diabetic kidney disease: from epidemiology to clinical perspectives. Diabetes Metab. J. 38, 252 (2014).

Article  PubMed  PubMed Central  Google Scholar 

Palmer, M. B. et al. The role of glomerular epithelial injury in kidney function decline in patients with diabetic kidney disease in the TRIDENT Cohort. Kidney Int. Rep. 6, 1066–1080 (2021).

Article  PubMed  PubMed Central  Google Scholar 

Coresh, J. et al. Change in albuminuria and subsequent risk of end-stage kidney disease: an individual participant-level consortium meta-analysis of observational studies. Lancet Diabetes Endocrinol. 7, 115–127 (2019).

Article  CAS  PubMed  PubMed Central  Google Scholar 

Di Pino, A. et al. High glomerular filtration rate is associated with impaired arterial stiffness and subendocardial viability ratio in prediabetic subjects. Nutr. Metab. Cardiovasc. Dis. 31, 3393–3400 (2021).

Article  PubMed  Google Scholar 

Mogensen, C. E. & Christensen, C. K. Predicting diabetic nephropathy in insulin-dependent patients. N. Engl. J. Med. 311, 89–93 (1984).

Article  CAS  PubMed  Google Scholar 

Mogensen, C. E. & Christensen, C. K. Microalbuminuria predicts clinical proteinuria and early mortality in maturity-onset diabetes. N. Engl. J. Med. 310, 356–360 (1984).

Article  CAS  PubMed  Google Scholar 

Pasternak, M. et al. Association of albuminuria and regression of chronic kidney disease in adults with newly diagnosed moderate to severe chronic kidney disease. JAMA Netw. Open 5, e2225821 (2022).

Article  PubMed  PubMed Central  Google Scholar 

Ninomiya, T. et al. Albuminuria and kidney function independently predict cardiovascular and renal outcomes in diabetes. J. Am. Soc. Nephrol. 20, 1813–1821 (2009).

Article  PubMed  PubMed Central  Google Scholar 

Drexler, Y. et al. Associations between albuminuria and mortality among US adults by demographic and comorbidity factors. J. Am. Heart Assoc. 12, e030773 (2023).

Article  CAS  PubMed  PubMed Central